Sunshine Biopharma Inc. cotiza a 0.24 USD y tiene una capitalización bursátil de $4M. En los últimos 12 meses ha facturado $35M con un margen de flujo de caja libre del -15.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavi…
| Periodo | 2026-05 | 2026-04 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-2.50 | $-4.60 | $-1.90 | $-3.90 |
| Estimado | $-1.60 | $-2.70 | $-1.30 | $-1.10 |
| Sorpresa | -56.2% | -70.4% | -46.2% | -254.5% |
| Métrica | SBFM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 33.8% | 57.0% | -23.3% |
| Operating Margin | -17.1% | -38.6% | +21.5% |
| Net Margin | -16.5% | -33.6% | +17.1% |
| FCF Margin | -15.2% | -13.9% | -1.3% |
| ROE | -25.9% | -40.4% | +14.5% |
| ROA | -19.9% | -32.0% | +12.1% |
| Current Ratio | 4.17 | 2.84 | +1.33 |
| Debt / Equity | — | 0.28 | — |